|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,238.00 GBX | +1.56% |
|
+5.27% | +20.90% |
| 08-03 | Indivior Pharmaceuticals, Inc. Enters into Senior Secured Term Loan Facility | CI |
| 08-03 | Indivior Pharmaceuticals, Inc. Proposes Special Cash Dividend | CI |
Performance
| 1 week | +5.27% | ||
| 1 month | +20.78% | ||
| 3 months | +60.36% | ||
| 6 months | +29.91% | ||
| Current year | +20.90% | ||
| 1 year | +49.52% | ||
| 3 years | -20.18% | ||
| 5 years | +107.02% |
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (GBX)
4,581,289,854
Market Cap (USD)
4,581,289,854
Net sales (USD)
1,239,000,000
Free-Float
97.98 %
Free-Float capitalization (GBX)
4,488,946,041
Free-Float capitalization (USD)
4,488,946,041
Indicators
Moving average 5 days
1,202.2
Moving average 100 days
895.46
Price spread / (MMA5)
-2.89%
Price spread / (MMA100)
-27.67%
RSI 9 days
0
RSI 14 days
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.56% | +5.27% | +49.52% | -20.18% | 4.58B | |
| -0.52% | +3.21% | +89.52% | +125.32% | 1,057B | |
| +0.88% | +1.13% | +49.56% | +49.79% | 625B | |
| +0.89% | -1.95% | +24.23% | +63.19% | 435B | |
| +0.71% | +3.87% | +49.07% | +38.29% | 363B | |
| +0.64% | -0.49% | +33.94% | +38.94% | 296B | |
| +0.39% | -5.83% | +8.92% | +6.39% | 249B | |
| +1.51% | +6.69% | +42.58% | +58.47% | 222B | |
| +3.92% | -0.46% | -5.56% | -51.70% | 209B | |
| +1.80% | +2.30% | +11.56% | +66.16% | 165B | |
| Average | +1.14% | +0.94% | +35.33% | +37.47% | 362.54B | |
| Weighted average by Cap. | +0.66% | +1.33% | +48.72% | +63.75% |
Historical Quotes: Indivior Pharmaceuticals, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| 1 week | 1,160 |  | 1,264 |
| 1 month | 975.5 | | 1,264 |
| 3 years | 554.83 | | 2,020 |
| 5 years | 335 | | 2,020 |
Monthly variations
Annual variations
| 2025 | -.--% | ||
| 2025 | +20.90% | ||
| 2024 | -13.59% | ||
| 2023 | -36.02% | ||
| 2022 | +44.12% | ||
| 2021 | +136.21% | ||
| 2020 | +178.97% | ||
| 2019 | -65.29% | ||
| 2018 | -72.48% | ||
| 2017 | +37.81% | ||
| 2016 | +57.72% | ||
| 2015 | +25.70% |
- Stock Market
- Stocks
- INDV Stock
- INDV Stock
- Quotes Indivior Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
